$30,000 of OMEROS CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Monitored separate payment policy for nonopioid alternatives. Issues involving rare disease therapies. Issues related to rare pediatric disease and Priority Review Vouchers (PRVs)."
You can find more data on corporate lobbying on Quiver Quantitative.
OMER Hedge Fund Activity
We have seen 59 institutional investors add shares of OMER stock to their portfolio, and 62 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY added 595,199 shares (+78.3%) to their portfolio in Q2 2025, for an estimated $1,785,597
- NOMURA HOLDINGS INC removed 590,459 shares (-87.0%) from their portfolio in Q2 2025, for an estimated $1,771,377
- TWO SIGMA INVESTMENTS, LP added 564,580 shares (+534.4%) to their portfolio in Q2 2025, for an estimated $1,693,740
- DEEPCURRENTS INVESTMENT GROUP LLC added 528,129 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,584,387
- TWO SIGMA ADVISERS, LP added 407,300 shares (+2627.7%) to their portfolio in Q2 2025, for an estimated $1,221,900
- RENAISSANCE TECHNOLOGIES LLC added 382,700 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,148,100
- BLACKROCK, INC. removed 332,144 shares (-7.6%) from their portfolio in Q2 2025, for an estimated $996,432
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
OMER Analyst Ratings
Wall Street analysts have issued reports on $OMER in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- D. Boral Capital issued a "Buy" rating on 09/03/2025
- HC Wainwright & Co. issued a "Buy" rating on 06/10/2025
To track analyst ratings and price targets for OMER, check out Quiver Quantitative's $OMER forecast page.
OMER Price Targets
Multiple analysts have issued price targets for $OMER recently. We have seen 2 analysts offer price targets for $OMER in the last 6 months, with a median target of $22.5.
Here are some recent targets:
- Jason Kolbert from D. Boral Capital set a target price of $36.0 on 09/03/2025
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $9.0 on 06/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
